期刊文献+

建立嵌合体诱导移植免疫耐受的研究进展 被引量:1

建立嵌合体诱导移植免疫耐受的研究进展
下载PDF
导出
摘要 建立器官免疫耐受是维持移植器官长期存活的理想境界。目前,在临床上应用的诱导免疫耐受的方案主要有:建立混合嵌合体;应用阻断共刺激通路的抗体;删除T细胞[1]。其中建立嵌合体是诱导器官免疫耐受的重要途径。本文就嵌合体的概念、种类、建立嵌合体的方法及其诱导免疫耐受的机理,嵌合体的检测及临床应用的研究进展作一综述。 The establishment of immune tolerance to organ transplant is to maintain long-term survival of Utopia. At present, the clinical application of immune tolerance induced by the program include: the establishment of mixed chimerism; application of costimulatory pathway blocking antibodies; removal of T-cell. Which is a chimera immune tolerance induced organ an important way. This paper includes the following aspects: the concept of chimerism, type, methods and the establishment of the mechanism of immune toler...
机构地区 广东医学院
出处 《当代医学》 2008年第14期25-26,共2页 Contemporary Medicine
关键词 器官移植 免疫耐受 嵌合体 organ transplantation immune tolerance chimerism
  • 相关文献

参考文献2

二级参考文献18

  • 1李素霞,达万明,高春记,朱海燕,王书红,薄剑,靖彧,靳海杰.STR-PCR对造血干细胞移植后植入证据的检测[J].中国实验血液学杂志,2005,13(1):25-29. 被引量:6
  • 2Bader P, Kreyenberg H, Hoelle W, et al. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: passible role for pre-emptive immunotherapy? J Clin Oncol,2004,22 : 1696-1705.
  • 3Khan F, Agarwal A, Agrawal S. Significance of chimerism in hematopoietie stem cell transplantation: new variations on an old theme. Bone Marrow Transplant, 2004,34 : 1-12.
  • 4Massenkeil G, Nagy M, Lawang M, et al. Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukemias if complete donor chimerism can be achieved. Bone Marrow Transplant, 2003,31:339-345.
  • 5Antin JH, Childs R, Filipovich AH, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation : recommendation from a workshop at the 2001 Tandem Meeting of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant, 2001, 7:473-485,
  • 6Peggs KS, Thomson K, Hart DP, et al. Dose-escalated donor lymphocyte infusions following reduced intensity transplantation:toxicity, chimerism, and disease responses. Blood, 2004, 103:1548-1556.
  • 7Marks D, Lush R, Cavenagh J, et al. The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation. Blood, 2002, 100 : 3108-3114.
  • 8Bader P,Klingebiel T,Schaudt A,et al.Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixedchimerism:a single center experience of 12 children.Leukemia,1999;13:2079-2086
  • 9Dubovsky J,Daxberger H,Fritsch G,et al.Kinetics of chimerism during the early post -transplant period in pediatric patients with malignant and non-malignant hematologic disorders:implication for timely detection of engraftment,graft failure and rejection.Leukemia,1999; 13:2059,2060-2069
  • 10Thiede C,Florek M,Bornhauser M,et al.Rapid quantification mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescene detection.Bone Marrow Transplant,1999;23:1055-1059

共引文献10

同被引文献28

  • 1马朝来,张同琳,王坤,孙和新.FK506预处理下骨髓移植诱导同种异体小鼠皮肤移植耐受的实验研究[J].中国微创外科杂志,2004,4(5):438-440. 被引量:10
  • 2檀英霞,王捷熙,李明,章扬培.建立人/猪造血嵌合体模型的初步探讨[J].中国实验血液学杂志,2005,13(4):673-676. 被引量:5
  • 3陈宝安,熊辉霞,丁家华,苏恩本,赵刚,王骏,高冲,孙耘玉,程坚.非清髓异基因外周血造血干细胞移植后嵌合体分析[J].中国实验血液学杂志,2006,14(2):313-317. 被引量:6
  • 4柏宏伟,石炳毅,钱叶勇,那彦群,曾瑄,钟定荣,武莎菲,陆敏,常京元,周文强.肾脏移植物血管内皮细胞嵌合现象预后观察[J].军医进修学院学报,2007,28(1):4-6. 被引量:2
  • 5Wekerle T.Transplantation tolerance induced bymixed chimerism.Jheart LungTransplant.2002,20:816-823.
  • 6Billingham RE,Brent L,Medawar PB."Actively acquired tolerance" of foreigncells.Nature.1953; 172:603.
  • 7MillerJ,MathewJM,Esquenazi V.Toward tolerance to human organ transplants:a few additional corollaries and questions.Transplantation.2004;6(77):940-942.
  • 8Hesselink DA,Van Hest RM,Mathot RA,et al.Cyclosporine interacts with mycophenolate mofetil by inhibiting the multidrug resistance-associated protein 2.Am Transpl.2005:5:987-994.
  • 9Ricordi C,Karatzas T,Selvaggi G,et al.Multiple bone marrow infusions toenhance acceptance of allografts from the same donor.Ann N YAcad Sci.1995; 770:345.
  • 10Hill P,Gagliardini E,Ruggenenti P,et al.Severe early acute humoral rejection resulting in allograft loss in a renal transplant recipient with Campath-1 H induction therapy.Nephrol Dial Transplant.2005; 20(8):1741-1744.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部